CapsoVision (CV) Interest & Investment Income (2024 - 2025)
CapsoVision (CV) reported Interest & Investment Income of $94000.0 for Q4 2025, up 2250.0% on a YoY basis from $4000.0 in Q4 2024, and down 28.79% sequentially from $132000.0 in Q3 2025.
CapsoVision (CV) Interest & Investment Income (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Interest & Investment Income data on file, last reported at $94000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 2250.0% year-over-year to $94000.0; the trailing twelve-month figure through Dec 2025 stood at $267000.0 (changed N/A YoY), and the FY2025 full-year result was $269000.0, up 934.62% from the prior year.
- Interest & Investment Income declined to $94000.0 in Q4 2025, from $132000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $132000.0 in Q3 2025 to a low of $4000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | CapsoVision | 163.05 Mn | 152.94 Mn | 1.95 Mn | 94,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 5,000.00 |